It was learned that according to a disclosure by the Hong Kong Stock Exchange on January 29, Sirio Pharma Co.,Ltd. (Sirio Pharma, 300791.SZ) has submitted a listing application for the main board, with CITIC Securities acting as its sole sponsor. The company is a leading provider of nutritional health food solutions; according to data from CIC, based on 2024 revenue, it holds the third-largest market share in the global nutritional health food solutions market and ranks first in the Chinese market. Furthermore, based on information from CIC, by 2024 revenue, the company is positioned as the world's second-largest provider of gummy and soft capsule nutritional health food solutions. According to the prospectus, the company was founded in 1993. With a deepening understanding of health needs, its strategic focus has gradually shifted from pharmaceuticals to the nutritional health food sector. Over the course of 33 years of robust development, the company has established a comprehensive portfolio of solutions, encompassing a full range of product formats for all demographics, supported by a diverse client base across multiple business models.